Pfizer 2014 Annual Report Download - page 53

Download and view the complete annual report

Please find page 53 of the 2014 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 75

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75

PFIZER ANNUAL REVIEW 2014 www.pzer.com/annual 53
ANNUAL REVIEW 2014
Our Science > Leading Consumer Healthcare Products
LEADING CONSUMER HEALTHCARE PRODUCTS
DELIVERING SCIENCE-BASED
SELF-CARE SOLUTIONS
Pfizer Consumer Healthcare’s products include over-the-counter (OTC) medicines,
supplements and other products that are top sellers in their categories and
household names for consumers around the world. They are an important part
of Pfizer’s commitment to providing a full spectrum of medicines, vaccines and
products to help people live healthier lives.
Products for gastrointestinal conditions are the fourth largest global
OTC category. The addition of Nexium® to the Pzer Consumer
Healthcare portfolio expands the categories in which we help
consumers better manage their health. During 2014, Nexium 24HR
launched in the United States, and Nexium Control launched in
Italy, France, Germany, Ireland, the Netherlands and Malta. Nexium
24HR recorded its rst sale in the U.S. at the end of May and, by
September, it was either the weekly market-share leader or battling
for that position in the U.S. OTC heartburn relief category — an
unprecedented achievement for a fourth-to-market product.
Learn more at nexium24hr.com
Nexium® is a registered trademark of AstraZeneca AB.
NEXIUM® OTC LAUNCH
AN UNPRECEDENTED SUCCESS